Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$51,552,727
+$1,478,683 QoQ
Shares Held
328,948
+0.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 3%
None 18%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. NVS ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,552,727 | 328,948 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $50,074,044 | 327,817 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $43,860,027 | 318,126 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $40,058,068 | 312,368 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $38,282,721 | 316,360 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $60,455,264 | 542,297 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $69,211,247 | 711,245 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $87,488,004 | 760,633 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $202,770,524 | 1,904,664 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $63,294,885 | 654,346 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $63,091,606 | 624,855 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $63,287,551 | 621,319 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $63,084,389 | 625,155 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $57,522,816 | 625,248 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $62,616,301 | 690,215 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $50,656,329 | 666,443 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $64,638,735 | 764,684 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $68,075,481 | 775,789 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $64,764,445 | 740,419 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $56,351,240 | 689,059 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $58,965,122 | 646,264 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $53,311,821 | 623,676 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $58,133,182 | 615,622 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $55,006,198 | 632,546 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $56,603,478 | 648,082 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $59,978,085 | 727,448 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||